STEVE SCOTT: Open Payments
NPI 1881283059 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 19 payments from 6 companies in 2025. Trend: 2023 $1,605 · 2024 $3,655 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $414 |
| Axsome Therapeutics, Inc. | 4 | $180 |
| Janssen Pharmaceuticals, Inc | 2 | $77 |
| ABBVIE INC. | 2 | $47 |
| Alkermes, Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: CAPLYTA, Auvelity, SPRAVATO, VRAYLAR, LYBALVI, REXULTI.
Industry payments across TX — which companies pay providers there.
